Base de dados : LILACS
Pesquisa : B01.650.940.800.575.912.250.238.374 [Categoria DeCS]
Referências encontradas : 1 [refinar]
Mostrando: 1 .. 1   no formato [Detalhado]

página 1 de 1

  1 / 1 LILACS  
             
seleciona
para imprimir
Fotocópia
Id: lil-356232
Autor: Meng, X. L; Riordan, N. H; Casciari, J. J; Zhu, Y; Zhong, J; González, M. J; Miranda-Massari, J. R; Riordan, H. D.
Título: Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis
Fonte: P. R. health sci. j;21(4):323-338, Dec. 2002.
Idioma: en.
Resumo: BACKGROUND: Plant materials represent promising sources of anti-cancer agents. We developed and tested a novel extract from the ubiquitous plant Convolvulus arvensis. MATERIALS AND METHODS: Convolvulus arvensis components were extracted in boiling water, and small molecules were removed by high-pressure filtration. The extract's biological activity was assessed by measuring its effects on S-180 fibrosarcoma growth in Kun Ming mice and on heparin-induced angiogenesis in chick embryos. We also examined the extract's effects on lymphocytes ex vivo and tumor cell growth in vitro. RESULTS: The extract (primarily proteins and polysaccharides) inhibited tumor growth in a dose-dependent fashion when administered orally. At the highest dose tested, 200 mg/kg/day, tumor growth was inhibited by roughly seventy percent. Subcutaneous or intraperitoneal administration at 50 mg/kg/day also inhibited tumor growth by over seventy percent. The extract's acute LD50 in Kun Ming mice was 500 mg/kg/day when injected, indicating that tumor growth inhibition occurred at non-toxic doses. It inhibited angiogenesis in chick embryos, improved lymphocyte survival ex vivo, and enhanced yeast phagocytosis, but did not kill tumor cells in culture. CONCLUSION: High molecular mass extract deserves further study as an anti-cancer agent.
Descritores: Convolvulus
Neoplasias/tratamento farmacológico
Neovascularização Patológica/tratamento farmacológico
Fitoterapia
Preparações de Plantas/uso terapêutico
-Células Cultivadas
Linfócitos/efeitos dos fármacos
Camundongos
Peso Molecular
Neoplasias/patologia
Limites: Humanos
Responsável: BR1.1 - BIREME



página 1 de 1
   


Refinar a pesquisa
  Base de dados : Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde